Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical Companies Vaccines

Moncef Slaoui Fired From GSK Role After Sexual Harassment Inquiry

Allegations Substantiated By External Investigators

Executive Summary

Pharma firm calls behaviour “wholly unacceptable” after external investigators back up employee allegations.

You may also be interested in...



Slaoui Apologizes For Sexual Harassment, Loses Further Industry Roles

The former Operation Warp Speed leader has apologized unreservedly for his actions, and loses positions with two biopharma companies.

Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model

In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.

Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy

The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.

Table

View full table

Topics

Related Companies

Tags:
BioPharmaceutical Companies Vaccines
Latest Headlines

How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies

IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Quotable: Words Of Wisdom From Our Recent APAC Coverage

See All
UsernamePublicRestriction

Register

SC144054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By